122 related articles for article (PubMed ID: 23879201)
1. Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.
Pulte D; Redaniel MT; Brenner H; Jansen L; Jeffreys M
Leuk Lymphoma; 2014 May; 55(5):1083-9. PubMed ID: 23879201
[TBL] [Abstract][Full Text] [Related]
2. Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).
Samy EF; Ross J; Bolton E; Morris EJ; Oliver SE
Leuk Lymphoma; 2015; 56(9):2660-7. PubMed ID: 25651425
[TBL] [Abstract][Full Text] [Related]
3. Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.
Libby E; Garcia D; Quintana D; Fekrazad MH; Bauman J; Ebaid A; Hromas R; Rabinowitz I; Wiggins C
Leuk Lymphoma; 2014 Dec; 55(12):2850-7. PubMed ID: 24588734
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma incidence, mortality, and survival differences at the intersection of sex, age, and race/ethnicity: A comparison between Puerto Rico and the United States SEER population.
Castañeda-Avila MA; Suárez-Ramos T; Torres-Cintrón CR; Epstein MM; Gierbolini-Bermúdez A; Tortolero-Luna G; Ortiz-Ortiz KJ
Cancer Epidemiol; 2024 Apr; 89():102537. PubMed ID: 38295555
[TBL] [Abstract][Full Text] [Related]
5. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.
Ailawadhi S; Aldoss IT; Yang D; Razavi P; Cozen W; Sher T; Chanan-Khan A
Br J Haematol; 2012 Jul; 158(1):91-8. PubMed ID: 22533740
[TBL] [Abstract][Full Text] [Related]
6. Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicity.
Castañeda-Avila MA; Jesdale BM; Beccia A; Bey GS; Epstein MM
Cancer Causes Control; 2021 Sep; 32(9):1021-1028. PubMed ID: 34089470
[TBL] [Abstract][Full Text] [Related]
7. Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?
Pulte D; Redaniel MT; Brenner H; Jeffreys M
Ann Oncol; 2012 Sep; 23(9):2428-2434. PubMed ID: 22396445
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008.
Goggins WB; Lo FF
Cancer Causes Control; 2012 May; 23(5):737-43. PubMed ID: 22450738
[TBL] [Abstract][Full Text] [Related]
9. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.
Pulte D; Jansen L; Castro FA; Emrich K; Katalinic A; Holleczek B; Brenner H;
Br J Haematol; 2015 Oct; 171(2):189-196. PubMed ID: 26123295
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups.
Pulte D; Redaniel MT; Jansen L; Brenner H; Jeffreys M
Haematologica; 2013 Feb; 98(2):222-9. PubMed ID: 22929974
[TBL] [Abstract][Full Text] [Related]
11. Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades.
Sun T; Wang S; Sun H; Wen J; An G; Li J
Leuk Lymphoma; 2018 Jan; 59(1):49-58. PubMed ID: 28595471
[TBL] [Abstract][Full Text] [Related]
12. Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States).
Gebregziabher M; Bernstein L; Wang Y; Cozen W
Cancer Causes Control; 2006 Sep; 17(7):931-8. PubMed ID: 16841260
[TBL] [Abstract][Full Text] [Related]
13. Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis.
Wei JX; Shastri A; Sica RA; Mantzaris I; Kornblum N; Shah U; Janakiram M; Gritsman K; Verma A; Goldfinger M; Cooper D; Shah N
Haematologica; 2024 May; 109(5):1480-1486. PubMed ID: 37881838
[TBL] [Abstract][Full Text] [Related]
14. Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.
Pulte D; Gondos A; Brenner H
Oncologist; 2011; 16(11):1600-3. PubMed ID: 21968047
[TBL] [Abstract][Full Text] [Related]
15. Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma.
Costa LJ; Huang JX; Hari PN
Biol Blood Marrow Transplant; 2015 Apr; 21(4):701-6. PubMed ID: 25555447
[TBL] [Abstract][Full Text] [Related]
16. Social disparities in survival after diagnosis with colorectal cancer: Contribution of race and insurance status.
Pulte D; Jansen L; Brenner H
Cancer Epidemiol; 2017 Jun; 48():41-47. PubMed ID: 28364671
[TBL] [Abstract][Full Text] [Related]
17. Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients.
Kaya H; Peressini B; Jawed I; Martincic D; Elaimy AL; Lamoreaux WT; Fairbanks RK; Weeks KA; Lee CM
Int J Hematol; 2012 Jan; 95(1):64-70. PubMed ID: 22160833
[TBL] [Abstract][Full Text] [Related]
18. Trends in survival from myeloma, 1990-2015: a competing risks analysis.
Sneyd MJ; Gray AR; Morison IM
BMC Cancer; 2021 Jul; 21(1):821. PubMed ID: 34271862
[TBL] [Abstract][Full Text] [Related]
19. Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
Pozzi S; Marcheselli L; Bari A; Liardo EV; Marcheselli R; Luminari S; Quaresima M; Cirilli C; Ferri P; Federico M; Sacchi S
Br J Haematol; 2013 Oct; 163(1):40-6. PubMed ID: 23889344
[TBL] [Abstract][Full Text] [Related]
20. Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.
Pulte ED; Nie L; Gormley N; Goldberg KB; McKee A; Farrell A; Pazdur R
Blood Adv; 2018 Jan; 2(2):116-119. PubMed ID: 29365319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
